<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01171612</url>
  </required_header>
  <id_info>
    <org_study_id>CIR2009017</org_study_id>
    <nct_id>NCT01171612</nct_id>
  </id_info>
  <brief_title>Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery</brief_title>
  <acronym>RegistStents</acronym>
  <official_title>Evaluation and Monitoring of Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate and monitor perioperative management of patients
      with coronary stents undergoing noncardiac surgery.

      Objectives:

        -  To describe the incidence and severity of adverse cardiovascular events in patients with
           coronary stents undergoing noncardiac surgery with admission.

        -  To assess the following-up of the guidelines about the perioperative management of
           antiplatelet therapy in these patients.

        -  To assess the relationship between the incidence of cardiac or neurovascular events, as
           well as bleeding complications with the perioperative management of antiplatelet
           therapy.

        -  Number of Participants with Adverse Events as a Measure of Safety
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      (Not desired)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiac and Cerebrovascular Events (MACCEs)</measure>
    <time_frame>up to 90 days after surgery</time_frame>
    <description>Cardiac Mortality, Myocardial Infarction, Angina Pectoris, new arrythmia, Congestive Heart Failure, Stroke, Cardiac Arrest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Haemorrhagic Events</measure>
    <time_frame>up to 90 days after surgery</time_frame>
    <description>Transfusion &gt; = 2 red blood cells Units, haemoglobin descent &gt;= 20 gr/dL, intracerebral haemorrhage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Adverse Events Related With Antiplatelet Therapy Management</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Perioperative withdrawal antiplatelet therapy is defined with &gt; or = 5 days without therapy
We create 3 categories:
Not withdrawal
Complete withdrawal (5 or &gt; days without antiplatelet drugs , mono or dual therapy)
Incomplete withdrawal: patients under dual antiplatelet therapy, who maintain aspirin and stopped clopidogrel =/ &gt; 5 days</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">483</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Coronary Stent Occlusion</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Coronary Stent</arm_group_label>
    <description>Patients with coronary Bare Metal Stent (BMS) or Drug Eluting Stent (DES) undergoing noncardiac surgery</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary stents undergoing noncardiac surgery with admission between May 2010
        and April 2012
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years old, with coronary stents

          -  American Society of Anaesthesia physical status II-V

          -  noncardiac surgery wiht admission

          -  informed consent

        Exclusion Criteria:

          -  &lt; 18 years old

          -  American Society of Anaesthesia physical status I

          -  ambulatory surgery

          -  pregnancy

          -  obstetric anaesthesia

          -  endoscopic procedures

          -  cardiac surgery

          -  not informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Rodriguez-Pont, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporacio Sanitaria Parc Tauli</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Municipal de Badalona</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Igualada</name>
      <address>
        <city>Igualada</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Mataró</name>
      <address>
        <city>Mataró</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Sabadell. Corporació Sanitària Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Sant Celoni</name>
      <address>
        <city>Sant Celoni</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica ASEPEYO</name>
      <address>
        <city>Sant Cugat del Valles</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sant Joan Despi Moisès Broggi</name>
      <address>
        <city>Sant Joan Despi</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Mútua de Terrassa</name>
      <address>
        <city>Terrassa</city>
        <state>Barcelona</state>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundació Puigvert - IUNA</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parc de Salut Mar-Esperança</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parc de Salut Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2010</study_first_submitted>
  <study_first_submitted_qc>July 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2010</study_first_posted>
  <results_first_submitted>August 13, 2013</results_first_submitted>
  <results_first_submitted_qc>September 16, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 25, 2013</results_first_posted>
  <last_update_submitted>March 8, 2016</last_update_submitted>
  <last_update_submitted_qc>March 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Anna Rodriguez Pont</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Coronary Stent</keyword>
  <keyword>BMS stent</keyword>
  <keyword>DES stent</keyword>
  <keyword>Date of stent implantation</keyword>
  <keyword>cardiac event</keyword>
  <keyword>neurovascular event</keyword>
  <keyword>Bleeding</keyword>
  <keyword>transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Observational, multicenter and prospective study, approved by the Ethics Committee. All patients with coronary stents undergoing noncardiac surgery with admission from February 2010 to April 2012 were the basis of the study.</recruitment_details>
      <pre_assignment_details>Patients scheduled for noncardiac surgery with admission</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Coronary Stent</title>
          <description>Patients with coronary Bare Metal Stent (BMS) or Drug Eluting Stent (DES) undergoing noncardiac surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="483"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="432"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>20 patienet were not taking previous antiplatelet agents</population>
      <group_list>
        <group group_id="B1">
          <title>Coronary Stent</title>
          <description>Patients with coronary Bare Metal Stent (BMS) or Drug Eluting Stent (DES) undergoing noncardiac surgery</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="432"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>age &lt; or = 70 years old age &gt; 70 years old</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Between 18 and 70 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;70 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="213"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="360"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="432"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>Kgm^2</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.9" lower_limit="18.0" upper_limit="50.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Antiplatelet Therapy</title>
          <description>patients taking previous aspirin, clopidogrel or both</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Antiplatelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="412"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not antiplatelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Major Adverse Cardiac and Cerebrovascular Events (MACCEs)</title>
        <description>Cardiac Mortality, Myocardial Infarction, Angina Pectoris, new arrythmia, Congestive Heart Failure, Stroke, Cardiac Arrest</description>
        <time_frame>up to 90 days after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Coronary Stent</title>
            <description>Patients with coronary Bare Metal Stent (BMS) or Drug Eluting Stent (DES) undergoing noncardiac surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Major Adverse Cardiac and Cerebrovascular Events (MACCEs)</title>
          <description>Cardiac Mortality, Myocardial Infarction, Angina Pectoris, new arrythmia, Congestive Heart Failure, Stroke, Cardiac Arrest</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="432"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Haemorrhagic Events</title>
        <description>Transfusion &gt; = 2 red blood cells Units, haemoglobin descent &gt;= 20 gr/dL, intracerebral haemorrhage</description>
        <time_frame>up to 90 days after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Coronary Stent</title>
            <description>Patients with coronary Bare Metal Stent (BMS) or Drug Eluting Stent (DES) undergoing noncardiac surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Major Haemorrhagic Events</title>
          <description>Transfusion &gt; = 2 red blood cells Units, haemoglobin descent &gt;= 20 gr/dL, intracerebral haemorrhage</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="432"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Adverse Events Related With Antiplatelet Therapy Management</title>
        <description>Perioperative withdrawal antiplatelet therapy is defined with &gt; or = 5 days without therapy
We create 3 categories:
Not withdrawal
Complete withdrawal (5 or &gt; days without antiplatelet drugs , mono or dual therapy)
Incomplete withdrawal: patients under dual antiplatelet therapy, who maintain aspirin and stopped clopidogrel =/ &gt; 5 days</description>
        <time_frame>90 days after surgery</time_frame>
        <population>MACCEs</population>
        <group_list>
          <group group_id="O1">
            <title>Not Withdrawal Antiplatelet Therapy</title>
            <description>Patients wiht aspirin and/or clopidogrel withdrawal for 5 or more days</description>
          </group>
          <group group_id="O2">
            <title>Incomplete Withdrawal (Mantaining ASA, Clopidogrel Withdrawn)</title>
            <description>Patients under dual antiplatelet therapy, wich maintain aspirin, and withdrawn clopidogrel 5 or more days</description>
          </group>
          <group group_id="O3">
            <title>Complete Withdrawal</title>
            <description>patients with aspirin oand/or clopidogrel, which stopped therapy &gt; 5 days</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Adverse Events Related With Antiplatelet Therapy Management</title>
          <description>Perioperative withdrawal antiplatelet therapy is defined with &gt; or = 5 days without therapy
We create 3 categories:
Not withdrawal
Complete withdrawal (5 or &gt; days without antiplatelet drugs , mono or dual therapy)
Incomplete withdrawal: patients under dual antiplatelet therapy, who maintain aspirin and stopped clopidogrel =/ &gt; 5 days</description>
          <population>MACCEs</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="294"/>
                <count group_id="O2" value="72"/>
                <count group_id="O3" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38" lower_limit="0.733" upper_limit="3.662"/>
                    <measurement group_id="O2" value="10" lower_limit="0.513" upper_limit="2.299"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Reference group were patients who maintained antiplatelet drugs (aspirin and/or clopidogrel) during the 4 days before surgery</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.479</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.086</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.513</ci_lower_limit>
            <ci_upper_limit>2.299</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.479</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.638</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.733</ci_lower_limit>
            <ci_upper_limit>3.662</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Perioperative events from surgery to 90 days after</time_frame>
      <desc>We registered the adverse events from surgery to 90 days after All the events were included in our outcomes definitions</desc>
      <group_list>
        <group group_id="E1">
          <title>Cardiac and Cerebrovascular Events</title>
          <description>Adverse events registered independently related with antiplatelet therapy management</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="432"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <description>In hospital Cardiac arrest</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="432"/>
              </event>
              <event>
                <sub_title>Cardiac Death</sub_title>
                <description>Death with cardiac origin</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="432"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="432"/>
              </event>
              <event>
                <sub_title>Unstable Angina</sub_title>
                <counts group_id="E1" events="39" subjects_affected="39" subjects_at_risk="432"/>
              </event>
              <event>
                <sub_title>Significant Arrythmia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="432"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="432"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.2</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="432"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke, Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="432"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Venous Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="432"/>
              </event>
              <event>
                <sub_title>Arterial ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="432"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This is a prospective and observational study</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Anna Rodriguez-Pont</name_or_title>
      <organization>Corporacion Sanitaria y Universitaria Parc Tauli</organization>
      <phone>0034937231010 ext 21283</phone>
      <email>anna.r.pont@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

